Use a scroll

Negev Capital

Negev Capital is an early-stage venture capital fund that primarily targets companies with medications that are at an early stage of clinical development.

Negev Capital

Business area

Venture capital fund



Invested in



Negev Capital

Negev Capital is a psychedelic medical intervention investment fund with assets of $30+ million. The Company invests in drug discovery, with a focus on preclinical and/or Phase 1 stages of development. They aim to support those early-stage companies in need of capital that promote the thoughtful, responsible, medical use of psychedelic medication for psychiatric disorders, and who have excellent management and science teams, and solid IP.